WRBY
Warby Parker Inc.
$27.59
-0.32 (-1.15%)
At close · Jul 16
Market Cap
$3.39B
Shares
122,715,236
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$871.91M
+13%
FY2025
Net Income
$1.64M
+108%
FY2025
Gross Margin
53.97%
-1.4pp
FY2025
Operating Margin
-0.61%
+3.3pp
FY2025
Diluted EPS
$0.01
+105.9%
FY2025
Operating Cash Flow
$110.79M
+12.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|
| $959M – $976M | $890.57M | $871.91M | $771.32M | $669.77M | $598.11M | $540.8M | $393.72M | $370.46M | |
| — | $414.93M | $401.33M | $344.48M | $304.54M | $257.05M | $223.05M | $161.78M | $147.36M | |
| — | $475.64M | $470.58M | $426.83M | $365.22M | $341.06M | $317.75M | $231.94M | $223.11M | |
| — | — | 53.97% | 55.34% | 54.53% | 57.02% | 58.76% | 58.91% | 60.22% | |
| — | $481.78M | $475.92M | $456.95M | $437.22M | $452.27M | $461.41M | $287.57M | $224.77M | |
| — | — | $50.28M | $45.87M | $38.55M | $31.86M | $21.55M | $17.76M | $14.52M | |
| — | -$6.14M | -$5.34M | -$30.11M | -$72M | -$111.2M | -$143.66M | -$55.63M | -$1.66M | |
| — | — | -0.61% | -3.9% | -10.75% | -18.59% | -26.56% | -14.13% | -0.45% | |
| — | — | $44.94M | $15.75M | -$33.44M | -$79.34M | -$122.11M | -$37.87M | $12.85M | |
| — | $8.26M | $8.38M | $10.6M | $9.23M | $1.31M | -$347K | -$97K | $1.94M | |
| — | $2.12M | $3.04M | -$19.52M | -$62.76M | -$109.9M | -$144.01M | -$55.73M | $276K | |
| — | $769K | $1.4M | $875K | $433K | $497K | $263K | $190K | $276K | |
| — | $1.35M | $1.64M | -$20.39M | -$63.2M | -$110.39M | -$144.27M | -$55.92M | $0 | |
| — | — | 0.19% | -2.64% | -9.44% | -18.46% | -26.68% | -14.2% | 0% | |
| — | $1.35M | $1.64M | -$20.39M | -$63.2M | -$110.39M | -$157.41M | -$55.92M | -$57.54M | |
| — | $1.47M | $2.1M | -$20.8M | -$64.08M | -$111.06M | -$144.36M | -$55.83M | $104K | |
| USD/shares | — | — | $0.01 | -$0.17 | -$0.54 | -$0.96 | -$2.21 | -$1.05 | -$1.10 |
| USD/shares | — | — | $0.01 | -$0.17 | -$0.54 | -$0.96 | -$2.21 | -$1.05 | -$1.10 |
| shares | — | — | 122.67M | 120.39M | 117.39M | 114.94M | 71.25M | 53.03M | 52.42M |
| shares | — | — | 125.1M | 120.39M | 117.39M | 114.94M | 71.25M | 53.03M | 52.42M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2019–FY2023: $87.56M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Instruments & Supplies median 1.89×
EV/EBIT
—
Medical Instruments & Supplies median 33.30×
P/E (TTM)
2,759.00×
Medical Instruments & Supplies median 37.88×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|
| Eyewear Products | $719,061,000 | $652,051,000 | $583,204,000 | $580,469,000 | $522,959,000 | $381,855,000 | $358,919,000 |
| Contacts Products | $97,153,000 | $78,753,000 | $57,889,000 | — | — | — | — |
| Services and Other | $55,691,000 | $40,511,000 | $28,672,000 | $17,643,000 | $17,839,000 | $11,864,000 | $11,544,000 |
| Shipping And Handling | $3,700,000 | $3,800,000 | $4,000,000 | $4,100,000 | $2,800,000 | $2,100,000 | $2,000,000 |
| Gift Card | — | — | — | — | $200,000 | $400,000 | $300,000 |
Key facts
CIK
1504776
CUSIP
93403J106
13F (30d)
25 filings
22 filers
Visit website
Investor relations